Similar articles

• [Interleukin-1(IL-1) alpha, beta, IL-1 receptor (IL-1R), IL-1 receptor antagonist (IL-1ra)].

  Hayashi H, Onozaki K. Hayashi H, et al. Nihon Rinsho. 2010 Jul;68 Suppl 7:62-6. Nihon Rinsho. 2010. PMID: 20960750 Japanese. No abstract available.
• Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.

  Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Gerber NJ. Seitz M, et al. J Rheumatol. 1996 Sep;23(9):1512-6. J Rheumatol. 1996. PMID: 8877917
• The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.

  Dayer JM. Dayer JM. Rheumatology (Oxford). 2003 May;42 Suppl 2:ii3-10. doi: 10.1093/rheumatology/keg326. Rheumatology (Oxford). 2003. PMID: 12817089 Review.
• Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.

  Jouvenne P, Vannier E, Dinarello CA, Miossec P. Jouvenne P, et al. Arthritis Rheum. 1998 Jun;41(6):1083-9. doi: 10.1002/1529-0131(199806)41:6<1083::AID-ART15>3.0.CO;2-9. Arthritis Rheum. 1998. PMID: 9627018
• Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism.

  Dinarello CA. Dinarello CA. Int J Tissue React. 1992;14(2):65-75. Int J Tissue React. 1992. PMID: 1399323 Review.